Coronavirus Update - 14th October 2020

Despite the recent rises in Covid-19 cases throughout the UK and Europe, Arcinova remains open for business at full capacity as we have done throughout this pandemic. As the situation continues to evolve, we will keep all our customers and stakeholders informed of our activities through this web-page which is updated on a regular basis.

We would like to take this opportunity to thank our clients and staff for their continued support over this period of restricted movement. 

We fully comply with all government guidance on minimising the risks of COVID-19 and have published our risk assessment here

Arcinova appoints new Non-Executive Director

Arcinova appoints new Non-Executive Director

“Internationally renowned Industry veteran Steve Bagshaw joins Arcinova board to propel continued industry-leading growth”

Arcinova, one of the fastest growing multi-service Contract Development and Manufacturing Organisations (CDMOs), is delighted to welcome Steve Bagshaw to its board as a Non-Executive Director. Steve has almost two decades of board level experience, including leadership roles within Japanese, American and UK Private Equity corporate cultures.  His proven acumen drove the rapid growth of a CDMO from $50m to over $600m turnover including transformational acquisitions both in Europe and the US.  

Steve’s appointment continues Arcinova’s strategy of strengthening the company board following the appointment of Roger Kilburn as CEO in 2019. Steve’s contribution will be pivotal to the continued growth of the business over the next few years, underpinned by the company’s investor, Business Growth Fund (BGF), who are fully supportive of our continued development.

With its board now complete, Arcinova looks to the future with renewed optimism and confidence. In line with the company’s growth strategy, Arcinova will look to make strategic acquisitions as appropriate to further enhance the scope and accessibility of its offerings to its international customer base. 

Steve Bagshaw commented, “I am delighted to be joining the team at Arcinova as a Non-Executive Director. The Leadership Team have already established an impressive track record and I have every confidence they will continue to grow the business rapidly. I am looking forward to working with them on this journey of growth.” 

Ian Shott, Executive Chairman at Arcinova, commented, “We are enormously privileged to welcome Steve to our board. His unparalleled experience will be invaluable to us as we continue the already remarkable journey of Arcinova.”



Discover how Arcinova can help

We provide a fully integrated approach to drug development, speak to our team and discover how we can help you fast forward to market.